These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32209047)

  • 41. Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategies.
    Vogel KR; Ainslie GR; Walters DC; McConnell A; Dhamne SC; Rotenberg A; Roullet JB; Gibson KM
    J Inherit Metab Dis; 2018 Jul; 41(4):699-708. PubMed ID: 29460030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Succinic semialdehyde dehydrogenase (SSADH) deficiency: Molecular analysis in a South American family.
    Lemes A; Blasi P; Gonzales G; Russi ME; Quadrelli R; Novelletto A; Malaspina P
    J Inherit Metab Dis; 2006 Aug; 29(4):587. PubMed ID: 16788854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood.
    Lapalme-Remis S; Lewis EC; De Meulemeester C; Chakraborty P; Gibson KM; Torres C; Guberman A; Salomons GS; Jakobs C; Ali-Ridha A; Parviz M; Pearl PL
    Neurology; 2015 Sep; 85(10):861-5. PubMed ID: 26268900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1
    Brown M; Turgeon C; Rinaldo P; Roullet JB; Gibson KM
    Mol Genet Metab; 2019 Dec; 128(4):397-408. PubMed ID: 31699650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Succinic Semialdehyde Dehydrogenase Deficiency in a Chinese Boy: A Novel ALDH5A1 Mutation With Severe Phenotype.
    Tay CG; Ariffin H; Yap S; Rahmat K; Sthaneshwar P; Ong LC
    J Child Neurol; 2015 Jun; 30(7):927-31. PubMed ID: 25122112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
    Booij J; Speelman JD; Horstink MW; Wolters EC
    Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.
    Tokatly Latzer I; Roullet JB; Afshar-Saber W; Lee HHC; Bertoldi M; McGinty GE; DiBacco ML; Arning E; Tsuboyama M; Rotenberg A; Opladen T; Jeltsch K; García-Cazorla À; Juliá-Palacios N; Gibson KM; Sahin M; Pearl PL
    J Neurodev Disord; 2024 Apr; 16(1):21. PubMed ID: 38658850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.
    Gibson KM; Christensen E; Jakobs C; Fowler B; Clarke MA; Hammersen G; Raab K; Kobori J; Moosa A; Vollmer B; Rossier E; Iafolla AK; Matern D; Brouwer OF; Finkelstein J; Aksu F; Weber HP; Bakkeren JA; Gabreels FJ; Bluestone D; Barron TF; Beauvais P; Rabier D; Santos C; Lehnert W
    Pediatrics; 1997 Apr; 99(4):567-74. PubMed ID: 9093300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
    Vogel KR; Ainslie GR; McConnell A; Roullet JB; Gibson KM
    Toxicol In Vitro; 2018 Feb; 46():203-212. PubMed ID: 29031482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation analysis and prenatal diagnosis in a Chinese family with succinic semialdehyde dehydrogenase and a systematic review of the literature of reported ALDH5A1 mutations.
    Liu N; Kong XD; Kan QC; Shi HR; Wu QH; Zhuo ZH; Bai QL; Jiang M
    J Perinat Med; 2016 May; 44(4):441-51. PubMed ID: 25431891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical features and ALDH5A1 gene findings in 13 Chinese cases with succinic semialdehyde dehydrogenase deficiency.
    Dong H; Ma X; Chen Z; Zhang H; Song J; Jin Y; Li M; Lu M; He R; Zhang Y; Yang Y
    BMC Med Genomics; 2024 Jun; 17(1):158. PubMed ID: 38862963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The first case of 4-hydroxybutyric aciduria in Japan.
    Ishiguro Y; Kajita M; Aoshima T; Watanabe K; Kimura M; Yamaguchi S
    Brain Dev; 2001 Mar; 23(2):128-30. PubMed ID: 11248463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Succinic semialdehyde dehydrogenase deficiency: an inheritable neurometabolic disease].
    Gahr M; Connemann BJ; Schönfeldt-Lecuona CJ; Freudenmann RW
    Fortschr Neurol Psychiatr; 2013 Mar; 81(3):154-61. PubMed ID: 23516105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.
    Kim KJ; Pearl PL; Jensen K; Snead OC; Malaspina P; Jakobs C; Gibson KM
    Antioxid Redox Signal; 2011 Aug; 15(3):691-718. PubMed ID: 20973619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age-related phenotype and biomarker changes in SSADH deficiency.
    DiBacco ML; Roullet JB; Kapur K; Brown MN; Walters DC; Gibson KM; Pearl PL
    Ann Clin Transl Neurol; 2019 Jan; 6(1):114-120. PubMed ID: 30656189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The characterization of psychotic symptoms in succinic semialdehyde dehydrogenase deficiency: a review.
    Colijn MA
    Psychiatr Genet; 2020 Dec; 30(6):153-161. PubMed ID: 33165204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
    Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
    Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.